Nevu Sp. z o.o.’s acquisition of Eubioco S.A., a producer of pharmaceuticals and dietary supplements, from Pelion S.A.


Chajec, Don-Siemion & Zyto has advised Nevu Sp. z o.o. on the acquisition of Eubioco S.A., a producer of pharmaceuticals and dietary supplements, from Pelion S.A., advised by Dentons.

Pelion is Poland’s largest healthcare sector corporation with annual turnover of more than PLN 9 billion and over 9,000 employees. The Pelion group has approximately 170 subsidiaries.

Dentons provided comprehensive advisory for this transaction, which included the drafting and negotiating of transaction documentation. Jakub Celinski led the Dentons team, supported by Capital Markets and M&A counsels Tomasz Dubij, Ryszard Manteuffel and Marcin Paliwoda.

The CDZ team was led by Partner Szymon Skiendzielewski (picture) and included Partners Andrzej Chajec, Jolanta Okoniecka, and Weronika Papucewicz, and Legal Advisors Eliza Szulc-Sieranska and Karolina Nowak-Rozycka.

Involved fees earner: Szymon Skiendzielewski – CDZ – Chajec, Don-Siemion & Zyto; Andrzej Chajec – CDZ – Chajec, Don-Siemion & Zyto; Jolanta Okoniecka – CDZ – Chajec, Don-Siemion & Zyto; Weronika Papucewicz – CDZ – Chajec, Don-Siemion & Zyto; Jakub Celinski – Dentons; Tomasz Dubij – Dentons; Ryszard Manteuffel – Dentons; Marcin Paliwoda – Dentons;

Law Firms: CDZ – Chajec, Don-Siemion & Zyto; Dentons;

Clients: Nevu Sp. z o.o.; Pelion S.A.;